TMCI

#3207
Treace Medical Concepts, Inc. Common Stock
1.86
-5.10%
Sector:
Base:
Profit Currency:
Daily Range
1.86
1.86
Year Range
1.81
9.53
Daily Change
-5.10%
Monthly Change
-26.77%
6 month change
-75.07%
Year Change
-79.05%
Previous Close
1.96
Open
1.86
Bid
Ask
Low
1.86
High
1.86
Volume
37
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 118.14 M
  • Employee 477
  • Founded 2014
  • CEO N/A
  • Website www.treace.com
  • Headquarter Florida, United States
  • FIGI BBG00GQKR6M4
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-8.27
Price to sales ratio
2.21
Dividends per share
—
Dividend yield %
—

Treace Medical Concepts Inc

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions. In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021.

News